期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Bioactivity-based UPLC/Q-TOF/MS strategy for screening of anti-inflammatory components from Cimicifugae Rhizoma 被引量:2
1
作者 Zeng-Yong Wang Qian Wang +4 位作者 Yan-Qi Han Min Jiang Jie Gao Yan Miao Gang Bai 《Chinese Chemical Letters》 SCIE CAS CSCD 2017年第2期476-481,共6页
In this study,the protective effects of Cimicifugae Rhizoma(CR) was demonstrated in Pseudomonas aeruginosa-induced pneumonia mouse model.To identify the anti-inflammatory ingredients,an ultraperformance liquid chrom... In this study,the protective effects of Cimicifugae Rhizoma(CR) was demonstrated in Pseudomonas aeruginosa-induced pneumonia mouse model.To identify the anti-inflammatory ingredients,an ultraperformance liquid chromatography quadrupole time-of-flight mass spectrometry(UPLC/Q-TOF-MS)integrated nuclear factor κB(NF-κB) luciferase reporter assay screening system was carried out.As a result,some caffeic acid derivatives,including caffeic acid,ferulic acid/isoferulic acid,fukinolic acid,and cimicifugic acid ingredients were identified as the potential effective compounds from CR.For testing the anti-inflammatory capacity,caffeic acid was demonstrated to inhibit NF-kB and reduce the levels of IL-6 and IL-8 in TNF-α-treated BEAS-2B cells in a dose-dependent manner.Hence,CR preparations and its cinnamic acid derivatives have the possibility to be developed as a complementary therapy in the treatment of respiratory system infection in clinics. 展开更多
关键词 cimicifugae rhizoma Pseudomonas aeruginosa Pneumonia NF-κB Caffeic acid derivatives
原文传递
Identification and differentiation of major components in three different “Sheng-ma” crude drug species by UPLC/Q-TOF-MS 被引量:4
2
作者 Mengxue Fan Kunming Qin +3 位作者 Fei Ding Yuting Huang Xiaoli Wang Baochang Cai 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2017年第2期185-192,共8页
Cimicifugae Rhizoma(Sheng ma) is a Ranunculaceae herb belonging to a composite family and well known in China,has been widely used in traditional Chinese medicine.The Pharmacopoeia of the People's Republic of Chin... Cimicifugae Rhizoma(Sheng ma) is a Ranunculaceae herb belonging to a composite family and well known in China,has been widely used in traditional Chinese medicine.The Pharmacopoeia of the People's Republic of China contains three varieties(Cimicifuga dahurica(Turcz.),Cimicifuga foetida L.and Cimicifuga heracleifolia Kom.) which have been used clinically as "Sheng-ma".However,the chemical constituents of three components of "Sheng-ma" have never been documented.In this study,a rapid method for the analysis of the main components of "Sheng-ma" was developed using ultra-high performance liquid chromatography with quadrupole-time-of-flight mass spectrometry(UPLC/Q-TOF-MS).The present study reveals the major common and distinct chemical constituents of C.dahurica,C.foetida and C.heracleifolia and also reports principal component and statistical analyses of these results.The components were identified by comparing the retention time,accurate mass,mass spectrometric fragmentation characteristic ions and matching empirical molecular formula with that of the published compounds.A total of 32 common components and 8 markers for different "Sheng-ma" components were identified.These findings provide an important basis for the further study and clinical utilities of the three "Sheng-ma" varieties. 展开更多
关键词 Sheng-ma Chemical profiling UPLC/Q-TOF-MS Chemical marker CIMICIFUGA cimicifugae rhizoma
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部